Nalaganje...
Emerging Evidence that ApoC-III Inhibitors Provide Novel Options to Reduce the Residual CVD
PURPOSE OF REVIEW: Apolipoprotein C-III (apoC-III) is known to inhibit lipoprotein lipase (LPL) and function as an important regulator of triglyceride metabolism. In addition, apoC-III has also more recently been identified as an important risk factor for cardiovascular disease. This review summariz...
Shranjeno v:
| izdano v: | Curr Atheroscler Rep |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer US
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6527792/ https://ncbi.nlm.nih.gov/pubmed/31111320 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11883-019-0791-9 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|